Ibandronate after prior bisphosphonate GI intoler.
Study Name:
PRIOR
Description:
Ibandronate (Boniva) oral monthly or i.v. Q3mos
Target Enrollment:
20
Start Date:
january
1, 2005
Stop Date:
july
30, 2005
Study Status:
ended
Study Title:
MK-217-072
Study Name:
Alendronate Evaluation
Description:
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Oral Alendronate Sodium, Conjugated Estrogens, and the Combination of Conjugated Estrogens with Alendronate Sodium for the Treatment of Postmenopausal Osteoporosis
Target Enrollment:
25
Start Date:
april
1, 1997
Stop Date:
july
30, 1998
Study Status:
ended
Study Title:
FOCAS
Study Name:
Oral Alendronate Sodium Study
Description:
A triple-blind, randomized, placebo-controlled multicenter study to compare efficacy of oral alendronate sodium to intranasal calcitonin-salmon for treatment of postmenopausal osteoporosis
Target Enrollment:
20
Start Date:
april
1, 1997
Stop Date:
august
31, 1999
Study Status:
ended
Study Title:
GGJY-CORE Continuing Outcomes of Raloxifene Evaluation
Study Name:
Raloxifene Evaluation
Description:
A Study of Raloxifene HCl and Placebo in the Prevention of Invasive Breast Cancer in Postmenopausal Women with Osteoporosis
